FDA Summary Review HQ SPCLT PHARMA NDA 205703

Summary Review

NDA 205703

HQ SPCLT PHARMA

Application #205703

Documents

Summary Review2016-10-20

Application Sponsors

NDA 205703HQ SPCLT PHARMA
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.